Influence of subject discontinuation on long-term nonvertebral fracture rate in the denosumab FREEDOM Extension study

BACKGROUND: Denosumab treatment for up to 8 years in the FREEDOM study and Extension was associated with low fracture incidence. It was not clear whether subjects who discontinued during the study conduct had a higher risk of fracture than those who remained enrolled, thereby underestimating the tru...

Descripción completa

Detalles Bibliográficos
Autores principales: Adachi, Jonathan D., Bone, Henry G., Daizadeh, Nadia S., Dakin, Paula, Papapoulos, Socrates, Hadji, Peyman, Recknor, Chris, Bolognese, Michael A., Wang, Andrea, Lin, Celia J. F., Wagman, Rachel B., Ferrari, Serge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408481/
https://www.ncbi.nlm.nih.gov/pubmed/28449657
http://dx.doi.org/10.1186/s12891-017-1520-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408481/
https://www.ncbi.nlm.nih.gov/pubmed/28449657
http://dx.doi.org/10.1186/s12891-017-1520-6

Ejemplares similares